Inventor · disambiguated record
Darragh Maccann
Also filed as: MACCANN DARRAGH
6 granted patents·9 pending applications·3 citations·filing 2019–2025
71Inventor score
Files withAMUNIX PHARMACEUTICALS INC7ARXX THERAPEUTICS AS3AQUALUNG THERAPEUTICS CORP2FUSION ANTIBODIES PLC2AQUALUNG THERAPEUTICS1
Top patents by PatentIndex Score
15 records- 0186US11466099B2Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodiesAQUALUNG THERAPEUTICS CORP·Filed 2021·Granted Oct 11, 2022·3 cites·19 claims
- 0277US12215156B2HER-2 targeted bispecific compositions and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2023·Granted Feb 4, 2025·0 cites·8 claims
- 0371US12428494B2Compositions targeting prostate-specific membrane antigen and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2025·Granted Sep 30, 2025·0 cites·8 claims
- 0471US2024327538A1Compositions targeting prostate-specific membrane antigen and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0566US2023220113A1Anti-human nicotinamide phosphoribosyltransferase (nampt) antibodiesAQUALUNG THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 0664US12304949B2Anti-S100A4 humanized antibodies, uses and methodsARXX THERAPEUTICS AS·Filed 2024·Granted May 20, 2025·0 cites·25 claims
- 0762US2023322922A1Her-2 targeted bispecific compositions and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0860US11142586B2Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodiesAQUALUNG THERAPEUTICS·Filed 2020·Granted Oct 12, 2021·0 cites·17 claims
- 0958US2025382726A1Antibody Library and MethodFUSION ANTIBODIES PLC·Filed 2025·Application pending·0 cites
- 1051US2021054077A1Cd3 antigen binding fragments and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1151US2023121775A1Cd3 antigen binding fragments and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1250US12378696B2Antibody library and methodFUSION ANTIBODIES PLC·Filed 2019·Granted Aug 5, 2025·0 cites·8 claims
- 1346US2024043521A1Anti-S100A4 Humanized Antibodies, Uses and MethodsARXX THERAPEUTICS AS·Filed 2022·Application pending·0 cites
- 1444US2023312729A1Egfr antigen binding fragments and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1536US2023220058A1Anti-S100A4 antibodies for the treatment of systemic sclerosisARXX THERAPEUTICS AS·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Darragh Maccann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →